Drug Profile


Alternative Names: RX 821037

Latest Information Update: 22 Jan 2001

Price : $50

At a glance

  • Originator Pierre Fabre
  • Class Antihyperglycaemics; Benzofurans; Imidazoles; Small molecules
  • Mechanism of Action Alpha 2 adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diabetes mellitus

Most Recent Events

  • 22 Jan 2001 Discontinued-II for Diabetes mellitus in United Kingdom (Unknown route)
  • 07 Jul 1999 No-Development-Reported for Diabetes mellitus in United Kingdom (Unknown route)
  • 12 Jul 1995 Phase-II clinical trials for Diabetes mellitus in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top